Mode
Text Size
Log in / Sign up

albuterol

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of albuterol

28 trials tracked of albuterol: 12 in phase 3 or 4 and 2 with published results. The most-cited published study has 257 citations.

28Trials tracked
12Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 5 Phase 3 7 Phase 2 6 Phase 1 2 Other / NA 8
  1. Phase 3 Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial Completed · 257 cited
  2. Phase 3 Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study) Completed · 1 cited
  3. Phase 4 A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma Completed
  4. Phase 4 A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma Completed
  5. Phase 4 Dose-response of Albuterol in Asthmatics Completed
  6. Phase 4 Effect of Nebulized Bronchodilators on Heart Rate Completed
Show 22 more trials
  1. Phase 4 Dose-Response of Salmeterol in Children Completed
  2. Phase 3 A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma Completed
  3. Phase 3 Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics Completed
  4. Phase 3 (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) Completed
  5. Phase 3 Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Completed
  6. Phase 3 Albuterol HFA MDI in Pediatric Participants With Asthma Completed
  7. Phase 2 Effect of Inhaled Albuterol in Pulmonary Hypertension Completed
  8. Phase 2 The Effect of Nebulized Albuterol on Donor Oxygenation Completed
  9. Phase 2 Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease Completed
  10. Phase 2 Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects Completed
  11. Phase 2 Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma Completed
  12. Phase 2 Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease Completed
  13. Phase 1 A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol Completed
  14. Phase 1 Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype Completed
  15. N/A Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma Completed
  16. N/A Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis Completed
  17. N/A The Various Effects of Gaseous Albuterol on Serum Lactate Completed
  18. N/A Characterization of Placebo Responses in Stable Asthma Completed
  19. N/A Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study Completed
  20. N/A Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults Completed
  21. N/A Respiratory Impedance and Obliterative Bronchiolitis Completed
  22. N/A Aerosolized Albuterol Use in Severe BPD Completed

Showing the 28 most-cited and recently-updated of 28 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.